TILInstil BioTIL info
$66.10info2.02%24h
Global rank12338
Market cap$429.91M
Change 7d-9.45%
YTD Performance807.97%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Instil Bio (TIL) Stock Overview

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

    TIL Stock Information

    Symbol
    TIL
    Address
    3963 Maple AvenueDallas, TX 75219United States
    Founded
    -
    Trading hours
    -
    Website
    https://instilbio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    972 499 3350

    Instil Bio (TIL) Price Chart

    -
    Value:-

    Instil Bio Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $66.10
    N/A
    Market Cap
    $429.91M
    N/A
    Shares Outstanding
    6.50M
    N/A
    Employees
    192.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org